Site Map
JapaneseThe pipeline shows the developmental status of an unapproved drug or an unapproved indication and is not intended to promote or advertise any of the drugs.
As of May 1, 2026
| Code | Target Indication/ Disease Area |
Preclinical | PhⅠ | PhⅡ | PhⅢ | NDA | MA | In-house/licensed-in |
|---|---|---|---|---|---|---|---|---|
| SK-5307 (paltusotine) |
Acromegaly Pituitary giantism |
 |
||||||
| SK-2407 | Dentatorubral-Pallidoluysian Atrophy (DRPLA) |   |